|
|
|
Insider
Information: |
Langer Robert |
Relationship: |
|
City: |
Newton |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
23,234,698 |
|
Indirect Shares
|
68,091 |
|
|
Direct
Value |
$64,517,299 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
23,302,789 |
|
|
Total
Value |
$64,517,299 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2008-08-08 |
950,022 |
|
0 |
Premium* |
|
Echo Therapeutics Inc |
ECTE |
Director |
2009-12-11 |
603,450 |
2004-05-26 |
0 |
Premium* |
|
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2013-06-05 |
7,433,628 |
|
0 |
Premium* |
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-26 |
738,424 |
|
0 |
Premium* |
|
Cartesian Therapeutics, Inc |
RNAC |
10% Owner |
2016-06-21 |
457,603 |
|
0 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-19 |
326,402 |
|
0 |
Premium* |
|
Moderna, Inc. |
MRNA |
Director |
2022-04-28 |
11,467,664 |
2022-04-28 |
42,396 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2019-10-14 |
0 |
2019-01-14 |
0 |
Premium* |
|
Korro Bio |
KRRO |
Director |
2020-11-17 |
214,326 |
2020-11-17 |
25,695 |
Premium* |
|
Lyra Therapeutics, Inc. |
LYRA |
Director |
2020-05-05 |
15,167 |
|
0 |
Premium* |
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-10-29 |
243,987 |
|
0 |
Premium* |
|
Seer, Inc. |
SEER |
|
2024-06-12 |
784,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2008-08-08 |
4 |
S |
$16.81 |
$336,200 |
D/D |
(20,000) |
950,022 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-04-13 |
4 |
S |
$2.39 |
$95,982 |
D/D |
(40,160) |
8,056,953 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-04-16 |
4 |
S |
$2.40 |
$383,616 |
D/D |
(159,840) |
7,897,113 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-06-26 |
4 |
S |
$2.42 |
$306,251 |
D/D |
(126,550) |
7,770,563 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-06-27 |
4 |
S |
$2.40 |
$32,280 |
D/D |
(13,450) |
7,757,113 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-06-28 |
4 |
S |
$2.30 |
$34,560 |
D/D |
(15,000) |
7,742,113 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-06-29 |
4 |
S |
$2.31 |
$57,167 |
D/D |
(24,780) |
7,717,333 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2012-07-02 |
4 |
S |
$2.39 |
$48,265 |
D/D |
(20,220) |
7,697,113 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2013-01-15 |
4 |
S |
$2.47 |
$87,587 |
D/D |
(35,436) |
7,661,677 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2013-01-16 |
4 |
S |
$2.46 |
$253,523 |
D/D |
(102,874) |
7,558,803 |
0 |
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2013-01-17 |
4 |
S |
$2.46 |
$129,076 |
D/D |
(52,425) |
7,506,378 |
0 |
- |
|
BIND |
DNIB Upwind Inc |
Director |
|
2016-08-26 |
4 |
OE |
$0.44 |
$6,600 |
D/D |
15,000 |
738,424 |
0 |
- |
|
RUBY |
Rubius Therapeutics, Inc. |
Director |
|
2019-01-14 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
RUBY |
Rubius Therapeutics, Inc. |
Director |
|
2019-04-15 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
RUBY |
Rubius Therapeutics, Inc. |
Director |
|
2019-07-15 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
RUBY |
Rubius Therapeutics, Inc. |
Director |
|
2019-10-14 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
703 |
11,467,664 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
939,264 |
|
- |
|
NVIV |
Invivo Therapeutics Holdi... |
10% Owner |
|
2010-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,262,360 |
|
- |
|
BIND |
DNIB Upwind Inc |
Director |
|
2013-09-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
723,424 |
|
- |
|
RNAC |
Cartesian Therapeutics, I... |
10% Owner |
|
2016-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
457,603 |
|
- |
|
KALA |
Kala Pharmaceuticals, Inc... |
Director |
|
2017-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
326,402 |
|
- |
|
KRRO |
Korro Bio |
Director |
|
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,695 |
|
- |
|
KRRO |
Korro Bio |
Director |
|
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
271,238 |
|
- |
|
LYRA |
Lyra Therapeutics, Inc. |
Director |
|
2020-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,499 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|